Phase I Study of PHL Treatment in Patients with Pancreatic Cancer
The purpose of this study to test the safety and feasibility of Paricalcitol, hydroxychloroquine, and losartan in patients with resectable pancreatic cancer.
Study ID: GI-174
Trial Phase: Phase I
Trial Sponsor: Fox Chase Cancer Center
Therapies Used in This Trial: Hydroxychloroquine, Losartan, Paricalcitol